Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
AI In Pharma Market Forecast: Value Set To Climb From $4.79 Billion To $11.12 Billion
The AI in pharma market has experienced substantial growth in its size over recent years. It is projected to expand significantly, rising from $3.78 billion in 2025 to $4.79 billion in 2026, achieving a compound annual growth rate (CAGR) of 26.9%. This historical growth can be ascribed to several factors, including the increase in pharmaceutical R&D spending, the expansion of biomedical data, the urgent need for faster drug development, the adoption of computational biology, and the escalating rise of chronic diseases.
The AI in pharma market is predicted to undergo significant expansion in the foreseeable future. It is set to achieve a size of $11.12 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 23.4%. This anticipated growth during the forecast period stems from the adoption of precision medicine, AI-driven clinical trials, the necessity for cost-effective drug discovery, the proliferation of personalized therapies, and the integration of genomics data. Noteworthy trends for this period encompass AI-guided drug discovery, optimization of clinical trials, development of predictive disease models, real-time patient data analytics, and automated research and development.
Get A Free Sample Report With In-Depth Market Insights:
AI In Pharma Market Growth Catalysts And Demand Drivers
The increased integration of cloud-based applications and services by pharmaceutical companies is anticipated to advance the expansion of the AI in pharma market in the future. Within the pharmaceutical industry, cloud-based drug discovery platforms offer an advanced method for conducting research and development. These platforms utilize data analytics and cloud computing technologies to enhance drug discovery procedures, providing a wide array of tools and functionalities vital for various facets of drug research and discovery. They improve the efficiency, cost-effectiveness, and collaboration of these processes. Pharmaceutical companies are key market participants and end-users of these platforms, which assist them in managing vast amounts of clinical, chemical, and biological data through secure storage options. For instance, in 2025, according to the Eurostat, a Luxembourg-based statistical office of the European Union, in 2023, 45% of EU businesses purchased cloud computing services. Large enterprises demonstrated a significantly higher tendency to adopt cloud solutions compared to SMEs, with 78% of large businesses employing cloud services against 44% of SMEs. Therefore, the expanding adoption of cloud-based applications and services by pharmaceutical companies will stimulate the AI in pharma market growth during the forecast period.
AI In Pharma Market Segmentation And Category Overview
The AI in pharma market covered in this report is segmented –
1) By Technology: Context-Aware Processing, Natural Language Processing, Querying Method, Deep Learning
2) By Drug Type: Small Molecule, Large Molecules
3) By Application: Diagnosis, Clinical Trial Research, Drug Discovery, Research and Development, Epidemic Prediction
Subsegments:
1) By Context-Aware Processing: Real-Time Data Processing, Contextual Recommendation Systems, Adaptive Learning Systems
2) By Natural Language Processing (NLP): Text Analytics And Sentiment Analysis, Chatbots And Virtual Assistants, Document And Data Mining
3) By Querying Method: Structured Querying, Unstructured Querying, Semantic Search Technologies
4) By Deep Learning: Neural Networks For Drug Discovery, Image Recognition For Medical Imaging, Predictive Analytics Models
AI In Pharma Market Trends Shaping Long-Term Demand
Leading companies in the AI in pharma market are concentrating on developing technological advancements, such as AI-powered medical consultation enhancement tools, to improve diagnostic accuracy, streamline clinical workflows, and support timely decision-making for healthcare professionals. These AI-powered tools utilize large language models (LLMs) to generate clinical summaries, automate documentation, and interpret patient-provided information, thereby optimizing physician efficiency. For instance, in October 2023, Ubie Inc., a Japan-based medical AI startup, introduced a generative AI-driven feature for doctors designed to streamline medical record documentation and summarize patient findings. This feature, known as the medical interview summary function, leverages an LLM to automatically condense 20–30 patient responses related to symptoms and lifestyle habits, which are collected through the Ubie Medical Navi platform. By presenting concise summaries directly on the doctor’s screen, the tool enables physicians to quickly understand patient concerns, reduce administrative burden, and enhance the overall quality and speed of medical consultations.
AI In Pharma Market Competitive Analysis Of Leading Industry Participants
Major companies operating in the AI in pharma market are Concerto HealthAI; Alphabet Inc.; OWKIN; Nvidia Corporation; PathAI; Insilico Medicine; Exscientia; Microsoft Corporation; XtalPi; Intel; Standigm; Takeda Pharmaceutical Company Ltd.; Otsuka Pharmaceutical Co. Ltd.; DeepMind; GlaxoSmithKline; Sanofi; Bayer; Renalytix AI; Merck; AstraZeneca; Iktos; Benevolent AI; Novartis; Ardigen; Botkin; Webiomed; Care Mentor AI; Diagnocat; IBM Corporation; Atomwise Inc.; Cloud Pharmaceuticals; Bioage; NuMedii; Envisagenics; Aria Pharmaceuticals; Verge Genomics; Berg LLC; Cyclica; IQVIA; Roche; Pfizer; PRA Health Sciences; Oncora Medical; Recursion Pharmaceuticals Inc.; Nucleai; Pepticom; Rology; hearX Group; iNNOHEALTH Technology Solutions
View The Full AI In Pharma Market Report:
AI In Pharma Market Top Region By Revenue And Market Share
North America was the largest region in the AI in pharma market in 2025. The regions covered in the AI in pharma market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.
